181
Participants
Start Date
September 8, 2017
Primary Completion Date
August 25, 2020
Study Completion Date
August 25, 2020
Peking University 3rd Hospital /ID# 213443, Beijing
The 7th People's Hospital of Shenyang /ID# 169829, Shenyang
2nd Aff. Hosp Harbin Med Univ /ID# 169827, Haerbin
Ruijin Hospital, Shanghai Jiaotong /ID# 169833, Shanghai
The Tenth People's Hospital of /ID# 169831, Shanghai
The First Affiliated Hospital /ID# 171398, Hefei
Shandong Provincial Hospital /ID# 169841, Jinan
Jing Tai Tianjin Hospital Co.,Ltd /ID# 208201, Tianjin
The Second Affiliated Hospital /ID# 169842, Hangzhou
Sir Run Run Shaw Hospital /ID# 169834, Jianggan Hangzhou
Dermatology Hospital of southe /ID# 169830, Guangzhou
Guangzhou 1st Muni People Hosp /ID# 208858, Guangzhou
The First Affiliated Hospital of Shantou University Medical College /ID# 209260, Shantou
Shenzhen Hospital of Southern /ID# 169828, Shenzhen
Traditional Chinese Medical Hospital of xinjiang uygur autonomous region /ID# 209183, Ürümqi
Lead Sponsor
AbbVie
INDUSTRY